Roche has added a novel treatment for rheumatoid arthritis to its early stage pipeline, one it says has the potential …
Financial communications consultancy FD has snapped up one of the UKs largest independent healthcare PR and med ed agencies.The acquisition …
Back in the 70s, pharmaceutical sales reps were detail men. They spent more time giving details to doctors about their …
Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …
The Conservative party has unveiled its vision for the NHS, including the scrapping of targets, the creation of an independent …
TVF Communications has scooped a brace of gold awards at the World Media Festival for its e-learning programs for Sanofi-Aventis' …
Optaflu has gained European approval for use against seasonal influenza. The Novartis drug is the first flu vaccine which does …
The largest new imaging centre in Europe – an £83 million collaboration between GlaxoSmithKline (GSK), Imperial College London and the …
GlaxoSmithKline has provided investors with details of a number of new oncology drugs it aims to launch over the next …
Every year could be called a watershed year for the NHS – it seems that constant change and reinvention is …
Lilly launches research effort to fight TBEli Lilly has announced the creation of a public-private partnership to conduct early-phase discovery …
Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …
Dr Reddy's Laboratories plans to become an R&D-based company are picking up pace with the opening of its first European …
Patricia Hewitt has dismissed the idea of making the NHS fully independent from politicians, first proposed by Gordon Brown a …
The future of Sanofi-Aventis' potential blockbuster Acomplia has been dealt a serious blow after an influential committee of FDA advisers …
Michael Moore's latest film opens at cinemas this month and has predictably raised passions with its critical dissection of the …
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
ProStrakan has unveiled Tostran in the UK, the first in a pan-European programme of product launches.Tostran is a testosterone replacement …
Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …
DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …